2796
D. Lee et al.
LETTER
ies to develop lead compounds for AChE inhibitors. The
biological evaluation of synthetic macakurzin C (3) and
its analogues are under way and will be reported in due
course.
HO
O
O
Ph
OBn
O
5
PhNEt2
250 °C, 4 h
93%
Acknowledgment
H
O
This work was supported by National Research Foundation of
Korea funded by the Ministry of Science, ICT & Future Planning
(NRF-2012R1A1A1009271).
HO
O
O
Ph
O
O
Ph
7
OBn
OBn
5
O
O
H
H
Supporting Information for this article is available online
A
at
B
10.1055/s-00000083.SunogIpimrfiantoSuIpg
n
fonirtat
ori
O
X
HO
O
O
Ph
O
O
O
Ph
7
References and Notes
+
(1) Uriarte-Pueyo, I.; Calvo, M. I. Curr. Med. Chem. 2011, 18,
5289.
(2) Thanh, V. T. T.; Mai, H. D. T.; Pham, V. C.; Litaudon, M.;
Dumontet, V.; Guéritte, F.; Nguyen, V. H.; Chau, V. M.
J. Nat. Prod. 2012, 75, 2012.
(3) Jain, A. C.; Zutshi, M. K. Tetrahedron 1973, 29, 3347.
(4) For a recent review on Claisen rearrangement, see: (a) Ilardi,
E. A.; Stivala, C. E.; Zakarian, A. Chem. Soc. Rev. 2009, 38,
3133. (b) Castro, A. M. M. Chem. Rev. 2004, 104, 2939.
(5) For a recent aromatic Claisen rearrangement, see: (a) Kim,
U. B.; Furkert, D. P.; Brimble, M. A. Org. Lett. 2013, 15,
658. (b) Park, I.-K.; Park, J.; Cho, C.-G. Angew. Chem. Int.
Ed. 2012, 51, 2496. (c) Adachi, M.; Higuchi, K.; Thasana,
N.; Yamada, H.; Nishikawa, T. Org. Lett. 2012, 14, 114.
(d) Ramadhar, T. R.; Kawakami, J.-I.; Lough, A. J.; Batey,
R. A. Org. Lett. 2010, 12, 4446.
OBn
3
5
OBn
O
OH
14
19
O
O
Ph
BCl3
CH2Cl2
total 9 steps
in overall 21% yield
from
OH
0 °C to r.t.
2 h, 83%
commercially available
phloroglucinol
OH
O
macakurzin C (3)
Scheme 5 Total synthesis of macakurzin C (3)
Having successfully prepared C(5) propargyl ether 5, we
embarked on the final stage of the synthesis (Scheme 5).
As expected, the subjection of 5 to the conventional con-
ditions of the aromatic Claisen rearrangement smoothly
provided 14 in 93% as a single isomer.
(6) Kim, H.; Lim, D.; Shin, I.; Lee, D. Tetrahedron 2014, 70,
4738.
(7) Gerard, B.; Cencic, R.; Pelletier, J.; Porco, J. A. Jr. Angew.
Chem. Int. Ed. 2007, 46, 7831.
Finally, the deprotection of the benzyl group with BCl3 in
CH2Cl2 completed the synthesis of macakurzin C (3) in
83% yield. The spectral data for synthetic 3 were identical
with those reported for the natural product (1H NMR,
13C NMR, IR, and HRMS).2
(8) Under the reaction conditions, the benzoyl group in 6 was
easily cleaved to afford bisphenol 16, which was rapidly
propargylated to afford the C(7) propargyl ether 12.
(9) For similar results on this type of aromatic Claisen
rearrangement of flavone and isoflavone, see: (a) Zheng, S.
Y.; Li, X. P.; Tan, H. S.; Yu, C. H.; Zhang, J. H.; Shen, Z.
W. Eur. J. Org. Chem. 2013, 1356. (b) Zheng, S. Y.; Shen,
Z. W. Tetrahedron Lett. 2010, 51, 2883.
(10) We also prepared the corresponding MOM-, PMB-, and Bn-
protected analogues of 17, which were tolerant to the
reaction conditions. However, the C(5) propargyl ether
groups were very susceptible to the various reaction
conditions of deprotection, resulting in the decomposition of
the starting materials.
In summary, the concise synthesis of macakurzin C (3)
has been accomplished in nine steps (21% overall yield)
from commercially available phloroglucinol, featuring a
sequential aromatic Claisen rearrangement and cycliza-
tion. We strongly believe that our synthetic routes could
provide a sufficient amount of 3, which would enable us
to extensively investigate in vitro/in vivo biological stud-
Synlett 2014, 25, 2794–2796
© Georg Thieme Verlag Stuttgart · New York